These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia. Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252 [TBL] [Abstract][Full Text] [Related]
3. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Harrison AA; Parsons LH; Koob GF; Markou A Psychopharmacology (Berl); 1999 Jan; 141(3):242-50. PubMed ID: 10027505 [TBL] [Abstract][Full Text] [Related]
4. Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration. O'Dell LE; Manzardo AM; Polis I; Stouffer DG; Parsons LH J Neurochem; 2006 Dec; 99(5):1363-76. PubMed ID: 17074068 [TBL] [Abstract][Full Text] [Related]
5. Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Müller CP; Carey RJ; Salloum JB; Huston JP Neuropharmacology; 2003 Apr; 44(5):592-603. PubMed ID: 12668045 [TBL] [Abstract][Full Text] [Related]
7. Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine. Yan Q; Reith ME; Yan S Brain Res; 2000 Apr; 863(1-2):254-8. PubMed ID: 10773215 [TBL] [Abstract][Full Text] [Related]
8. Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway. Boulenguez P; Rawlins JN; Chauveau J; Joseph MH; Mitchell SN; Gray JA Neuropharmacology; 1996; 35(11):1521-9. PubMed ID: 9025099 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Essman WD; Singh A; Lucki I Pharmacol Biochem Behav; 1994 Sep; 49(1):107-13. PubMed ID: 7816859 [TBL] [Abstract][Full Text] [Related]
10. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Navailles S; De Deurwaerdère P; Porras G; Spampinato U Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323 [TBL] [Abstract][Full Text] [Related]
11. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. O'Dell LE; Parsons LH J Pharmacol Exp Ther; 2004 Nov; 311(2):711-9. PubMed ID: 15226384 [TBL] [Abstract][Full Text] [Related]
12. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. Shippenberg TS; Hen R; He M J Neurochem; 2000 Jul; 75(1):258-65. PubMed ID: 10854269 [TBL] [Abstract][Full Text] [Related]
13. The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Müller CP; De Souza Silva MA; DePalma G; Tomaz C; Carey RJ; Huston JP Behav Brain Res; 2002 Aug; 134(1-2):337-46. PubMed ID: 12191821 [TBL] [Abstract][Full Text] [Related]
14. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects. Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241 [TBL] [Abstract][Full Text] [Related]
15. Dissociable roles for the dorsal and median raphé in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Szumlinski KK; Frys KA; Kalivas PW Neuropsychopharmacology; 2004 Sep; 29(9):1675-87. PubMed ID: 15127081 [TBL] [Abstract][Full Text] [Related]
16. 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats. Cervo L; Pozzi L; Samanin R Pharmacol Biochem Behav; 1996 Sep; 55(1):33-7. PubMed ID: 8870035 [TBL] [Abstract][Full Text] [Related]
17. Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Morgan AE; Horan B; Dewey SL; Ashby CR Eur J Pharmacol; 1997 Jul; 331(1):R1-3. PubMed ID: 9274936 [TBL] [Abstract][Full Text] [Related]
18. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience. Kosten TA; Zhang XY; Kehoe P J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857 [TBL] [Abstract][Full Text] [Related]
19. Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats. Gurkovskaya OV; Palamarchouk V; Smagin G; Goeders NE Synapse; 2005 Sep; 57(4):202-12. PubMed ID: 15986362 [TBL] [Abstract][Full Text] [Related]
20. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]